LymphedemaV1, Main, Exploration, bibRecord, 005E83

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis

Identifieur interne : 005E83 ( Main/Exploration ); précédent : 005E82; suivant : 005E84

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis

Auteurs : Masayuki Kubo [Japon] ; Tao-Sheng Li [Japon] ; Takahiro Kamota [Japon] ; Mako Ohshima [Japon] ; Bungo Shirasawa [Japon] ; Kimikazu Hamano [Japon]

Source :

Journal of vascular surgery [ 0741-5214 ] ; 2010.

RBID : Pascal:10-0396150

Descripteurs français

Pascal (Inist)
- Lymphoedème, Pathologie de l'appareil circulatoire, Onde choc, Traitement, Chirurgie.
Wicri :
- topic : Chirurgie.

English descriptors

KwdEn :
- Cardiovascular disease, Lymphedema, Shock wave, Surgery, Treatment.

Abstract

Objective: Although secondary lymphedema is a common complication after surgical and radiation therapy for cancer, the treatment options for lymphedema remain limited and largely ineffective. We thus studied the effect of extracorporeal shock wave therapy on promoting lymphangiogenesis and improving secondary lymphedema. Methods: A rabbit ear model of lymphedema was created by disruption of lymphatic vessels. Two weeks after surgery, the lymphedematous ear was treated with or without low-energy shock waves (0.09 mJ/mm², 200 shots), three times per week for 4 weeks. Results: Western blot analysis showed that the expression of vascular endothelial growth factor (VEGF)-C (1.23-fold, P < .05) and VEGF receptor 3 (VEGFR3; 1.53-fold, P < .05) was significantly increased in the ears treated with shock wave than in the untreated lymphedematous ears. Compared with the control group, shock wave treatment led to a significant decrease in the thickness of lymphedematous ears (3.80 ± 0.25 mm vs 4.54 ± 0.18 mm, P < .05). Immunohistochemistry for VEGFR3 showed the density of lymphatic vessels was significantly increased by shock wave treatment (P < .05). Conclusion: Extracorporeal shock wave therapy promotes lymphangiogenesis and ameliorates secondary lymphedema, suggesting that extracorporeal shock wave therapy may be a novel, feasible, effective, and noninvasive treatment for lymphedema.

Affiliations:

Japon

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: 000237
to stream PascalFrancis, to step Curation: 000721
to stream PascalFrancis, to step Checkpoint: 000255
to stream Main, to step Merge: 005F49
to stream Main, to step Curation: 005E83

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis</title>
<author><name sortKey="Kubo, Masayuki" sort="Kubo, Masayuki" uniqKey="Kubo M" first="Masayuki" last="Kubo">Masayuki Kubo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Tao Sheng" sort="Li, Tao Sheng" uniqKey="Li T" first="Tao-Sheng" last="Li">Tao-Sheng Li</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kamota, Takahiro" sort="Kamota, Takahiro" uniqKey="Kamota T" first="Takahiro" last="Kamota">Takahiro Kamota</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ohshima, Mako" sort="Ohshima, Mako" uniqKey="Ohshima M" first="Mako" last="Ohshima">Mako Ohshima</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shirasawa, Bungo" sort="Shirasawa, Bungo" uniqKey="Shirasawa B" first="Bungo" last="Shirasawa">Bungo Shirasawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hamano, Kimikazu" sort="Hamano, Kimikazu" uniqKey="Hamano K" first="Kimikazu" last="Hamano">Kimikazu Hamano</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0396150</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0396150 INIST</idno>
<idno type="RBID">Pascal:10-0396150</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000237</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000721</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000255</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000255</idno>
<idno type="wicri:doubleKey">0741-5214:2010:Kubo M:extracorporeal:shock:wave</idno>
<idno type="wicri:Area/Main/Merge">005F49</idno>
<idno type="wicri:Area/Main/Curation">005E83</idno>
<idno type="wicri:Area/Main/Exploration">005E83</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis</title>
<author><name sortKey="Kubo, Masayuki" sort="Kubo, Masayuki" uniqKey="Kubo M" first="Masayuki" last="Kubo">Masayuki Kubo</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Li, Tao Sheng" sort="Li, Tao Sheng" uniqKey="Li T" first="Tao-Sheng" last="Li">Tao-Sheng Li</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kamota, Takahiro" sort="Kamota, Takahiro" uniqKey="Kamota T" first="Takahiro" last="Kamota">Takahiro Kamota</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ohshima, Mako" sort="Ohshima, Mako" uniqKey="Ohshima M" first="Mako" last="Ohshima">Mako Ohshima</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Shirasawa, Bungo" sort="Shirasawa, Bungo" uniqKey="Shirasawa B" first="Bungo" last="Shirasawa">Bungo Shirasawa</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hamano, Kimikazu" sort="Hamano, Kimikazu" uniqKey="Hamano K" first="Kimikazu" last="Hamano">Kimikazu Hamano</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</s1>
<s3>JPN</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Japon</country>
<wicri:noRegion>Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of vascular surgery</title>
<title level="j" type="abbreviated">J. vasc. surg.</title>
<idno type="ISSN">0741-5214</idno>
<imprint><date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of vascular surgery</title>
<title level="j" type="abbreviated">J. vasc. surg.</title>
<idno type="ISSN">0741-5214</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cardiovascular disease</term>
<term>Lymphedema</term>
<term>Shock wave</term>
<term>Surgery</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Lymphoedème</term>
<term>Pathologie de l'appareil circulatoire</term>
<term>Onde choc</term>
<term>Traitement</term>
<term>Chirurgie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Chirurgie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Objective: Although secondary lymphedema is a common complication after surgical and radiation therapy for cancer, the treatment options for lymphedema remain limited and largely ineffective. We thus studied the effect of extracorporeal shock wave therapy on promoting lymphangiogenesis and improving secondary lymphedema. Methods: A rabbit ear model of lymphedema was created by disruption of lymphatic vessels. Two weeks after surgery, the lymphedematous ear was treated with or without low-energy shock waves (0.09 mJ/mm<sup>2</sup>
, 200 shots), three times per week for 4 weeks. Results: Western blot analysis showed that the expression of vascular endothelial growth factor (VEGF)-C (1.23-fold, P < .05) and VEGF receptor 3 (VEGFR3; 1.53-fold, P < .05) was significantly increased in the ears treated with shock wave than in the untreated lymphedematous ears. Compared with the control group, shock wave treatment led to a significant decrease in the thickness of lymphedematous ears (3.80 ± 0.25 mm vs 4.54 ± 0.18 mm, P < .05). Immunohistochemistry for VEGFR3 showed the density of lymphatic vessels was significantly increased by shock wave treatment (P < .05). Conclusion: Extracorporeal shock wave therapy promotes lymphangiogenesis and ameliorates secondary lymphedema, suggesting that extracorporeal shock wave therapy may be a novel, feasible, effective, and noninvasive treatment for lymphedema.</div>
</front>
</TEI>
<affiliations><list><country><li>Japon</li>
</country>
</list>
<tree><country name="Japon"><noRegion><name sortKey="Kubo, Masayuki" sort="Kubo, Masayuki" uniqKey="Kubo M" first="Masayuki" last="Kubo">Masayuki Kubo</name>
</noRegion>
<name sortKey="Hamano, Kimikazu" sort="Hamano, Kimikazu" uniqKey="Hamano K" first="Kimikazu" last="Hamano">Kimikazu Hamano</name>
<name sortKey="Kamota, Takahiro" sort="Kamota, Takahiro" uniqKey="Kamota T" first="Takahiro" last="Kamota">Takahiro Kamota</name>
<name sortKey="Li, Tao Sheng" sort="Li, Tao Sheng" uniqKey="Li T" first="Tao-Sheng" last="Li">Tao-Sheng Li</name>
<name sortKey="Ohshima, Mako" sort="Ohshima, Mako" uniqKey="Ohshima M" first="Mako" last="Ohshima">Mako Ohshima</name>
<name sortKey="Shirasawa, Bungo" sort="Shirasawa, Bungo" uniqKey="Shirasawa B" first="Bungo" last="Shirasawa">Bungo Shirasawa</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005E83 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005E83 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:10-0396150
   |texte=   Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis

Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri